No Data
No Data
Stocks that moved the previous day part2 include Ise Chemicals, Japan Avio, and Yamato Heavy Industries, etc.
Stock name <Code> 1-day closing price ⇒ Compared to the previous day KOA <6999> 1110 -23 turned into a significant decrease in earnings due to downward revision of performance. Pal Group HD <2726> 2459 +79 profit-taking selling predominates after a bounce. Systena <2317> 370 -1 Are factors such as unwinding selling of credit buy orders related to supply and demand? Lax <3923> 2205.5 -31.5 Facing headwinds such as rising long-term US interest rates. Sailor Advertising <2156> 412 +80 as one corner of local revitalization on the 30th.
Settlement reached concerning the injunction and damages claim for manufacturing and selling East Pharmaceutical products based on patent infringement against Shin Bio Pharmaceutical---Toa Pharmaceutical.
On the 30th, Cinbio Pharmaceuticals <4582> announced that it had reached a settlement with Toa Pharmaceutical <4553> regarding the lawsuit filed jointly with Eagle Pharmaceuticals of the USA on December 16, 2022, for patent infringement against Toa Pharmaceuticals and the injunction and claim for damages for the manufacture and sale of Toa products. The subject product of the lawsuit is Toa Pharmaceuticals' Trexine (R) Intravenous Infusion Solution 100mg/4mL that the company manufactures and sells.
Firm, is the market dominated by buying on dips following the sharp decline the previous day?
[Emerging markets individual stock strategy] Today's emerging markets are expected to show a strong performance. In the U.S. stock market on September 30th, the Dow Jones Industrial Average rose by $17.15 (+0.04%) to 42,330.15, slightly extending gains for the third day. Federal Reserve Chairman Powell's speech hinted at a slight pace of rate cuts, causing a temporary sharp decline due to disappointment, but by the end of the month, along with adjustments for the quarter-end, optimistic views on the economy from the chairman supported the stock prices. Nasdaq
Emerging market outlook: Will the Growth Market 250 Index take a break and individual stock picking strengthen with positive investor sentiment?
■ The emerging market this week has seen a significant increase in overall market conditions, with major stocks showing strength. During the same period, while the Nikkei Average increased by +0.79%, the Growth Market Index rose by +4.63% and the Growth Market 250 Index rose by +5.16%, highlighting the growth of the emerging market. Similar to the main board, trading volume has not expanded significantly, but driven by improved investor sentiment, major stocks with large market capitalization, such as constituents of the Growth Market Core Index, have shown overall strength. The Growth Market 250 Index opened on August 1st.
Part 2 of the previous day's moving stocks include M&A SOKO Holdings, Sakura Internet, Big Camera, etc.
Stock name (code) 20-day closing price ⇒ Previous day comparison Kitagawa Seiki <6327> 723-48. June 2015 operating profit is expected to decrease by 38%. MonotaRO <3064> 2,458.5-7. Sell off profits against the recent rise continues. Neo Marketing <4196> 1107 +20 Release a beta version of the new interview service "Chat AI Research DEMO!" that takes advantage of the latest AI technology. M&A Consulting Holdings <9552> 2785
Shin Bio Pharmaceutical initiates international collaborative phase 1b clinical trial targeting patients with malignant lymphoma with injection Brincidofovir.
On the 19th, Shionogi Pharmaceutical Co., Ltd. <4582> announced that it has submitted a clinical trial plan to the Pharmaceuticals and Medical Devices Agency on August 5, 2024 for an injection drug, Brincidofovir (IV BCV), for relapsed or refractory lymphoma patients (malignant lymphoma such as NK/T-cell lymphoma), and has started the Phase 1b/2 international clinical trial. The company has been conducting joint research on BCV with the Singapore National Cancer Centre, and in non-clinical trials of BCV...
No Data
No Data